| Patent | Date |
|---|
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20220265642 - Sampath; Deepak ; et al. | 2022-08-25 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
Grant 11,413,282 - Sampath , et al. August 16, 2 | 2022-08-16 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20220211696 - Sampath; Deepak ; et al. | 2022-07-07 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20220008413 - Sampath; Deepak ; et al. | 2022-01-13 |
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor
Grant 11,110,087 - Sampath , et al. September 7, 2 | 2021-09-07 |
Combination Therapy With An Anti-her2 Antibody-drug Conjugate And A Bcl-2 Inhibitor
App 20210213130 - Phillips; Gail Lewis ; et al. | 2021-07-15 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20210177838 - Sampath; Deepak ; et al. | 2021-06-17 |
Combination Of Bcl-2 Inhibitor And Mek Inhibitor For The Treatment Of Cancer
App 20210169865 - Merchant; Mark ; et al. | 2021-06-10 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
Grant 10,993,942 - Sampath , et al. May 4, 2 | 2021-05-04 |
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer
Grant 10,959,993 - Merchant , et al. March 30, 2 | 2021-03-30 |
Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor
Grant 10,898,570 - Phillips , et al. January 26, 2 | 2021-01-26 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20200253963 - Kind Code | 2020-08-13 |
Combination Of Bcl-2 Inhibitor And Mek Inhibitor For The Treatment Of Cancer
App 20180303815 - Merchant; Mark ; et al. | 2018-10-25 |
Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
Grant 10,092,567 - Lin , et al. October 9, 2 | 2018-10-09 |
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer
App 20180280408 - Belvin; Marcia ; et al. | 2018-10-04 |
Methods And Compositions For Treating Cancer Using Pd-1 Axis Antagonists And Hpk1 Antagonists
App 20180280505 - Hernandez; Sairy ; et al. | 2018-10-04 |
Combination Therapy With An Anti-her2 Antibody-drug Conjugate And A Bcl-2 Inhibitor
App 20180140700 - Phillips; Gail Lewis ; et al. | 2018-05-24 |
Methods and compositions for modulating estrogen receptor mutants
Grant 9,855,270 - Hager , et al. January 2, 2 | 2018-01-02 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20170281619 - Sampath; Deepak ; et al. | 2017-10-05 |
Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
Grant 9,717,730 - Lin , et al. August 1, 2 | 2017-08-01 |
Combinations of AKT and MEK inhibitor compounds, and methods of use
Grant 9,682,082 - Lee , et al. June 20, 2 | 2017-06-20 |
Combinations Of Akt Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
App 20170157124 - Lin; Kui ; et al. | 2017-06-08 |
Combinations of AKT inhibitor compounds and erlotinib, and methods of use
Grant 9,610,289 - Nannini , et al. April 4, 2 | 2017-04-04 |
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor
Grant 9,539,251 - Sampath , et al. January 10, 2 | 2017-01-10 |
Methods Of Treatment With Taselisib
App 20160375033 - Edgar; Kyle ; et al. | 2016-12-29 |
Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And A Cdk4/6 Inhibitor Compound For The Treatment Of Cancer
App 20160279142 - Friedman; Lori ; et al. | 2016-09-29 |
Combinations Of Akt Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
App 20160228440 - Lin; Kui ; et al. | 2016-08-11 |
Methods And Compositions For Treating Cancer Using Pd-1 Axis Antagonists And Hpk1 Antagonists
App 20160158360 - Hernandez; Sairy ; et al. | 2016-06-09 |
Combinations of AKT inhibitor compounds and abiraterone, and methods of use
Grant 9,346,789 - Nannini , et al. May 24, 2 | 2016-05-24 |
Combinations Of Akt Inhibitor Compounds And Erlotinib, And Methods Of Use
App 20160051550 - Nannini; Michelle ; et al. | 2016-02-25 |
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer
App 20160045515 - Belvin; Marcia ; et al. | 2016-02-18 |
Combinations of AKT inhibitor compounds and erlotinib, and methods of use
Grant 9,150,549 - Nannini , et al. October 6, 2 | 2015-10-06 |
Methods And Compositions For Modulating Estrogen Receptor Mutants
App 20150258099 - Hager; Jeffrey J. ; et al. | 2015-09-17 |
Therapeutic Combinations With Estrogen Receptor Modulators
App 20150258080 - Hager; Jeffrey J. ; et al. | 2015-09-17 |
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
Grant 9,107,926 - Belvin , et al. August 18, 2 | 2015-08-18 |
Combinations Of Akt Inhibitor Compounds And Chemotheraeptuc Agents, And Methods Of Use
App 20150064171 - Lin; Kui ; et al. | 2015-03-05 |
Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of Use
App 20140256691 - Nannini; Michelle ; et al. | 2014-09-11 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20140248262 - Sampath; Deepak ; et al. | 2014-09-04 |
Combinations Of Akt Inhibitor Compounds And Erlotinib, And Methods Of Use
App 20140221386 - Nannini; Michelle ; et al. | 2014-08-07 |
Combinations Of Akt And Mek Inhibitor Compounds, And Methods Of Use
App 20140155372 - Lee; Brian ; et al. | 2014-06-05 |
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer
App 20140044706 - Belvin; Marcia ; et al. | 2014-02-13 |
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use
Grant 8,604,014 - Belvin , et al. December 10, 2 | 2013-12-10 |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
Grant 8,247,397 - Belvin , et al. August 21, 2 | 2012-08-21 |
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
App 20110223619 - Belvin; Marcia ; et al. | 2011-09-15 |
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
App 20090098135 - Belvin; Marcia ; et al. | 2009-04-16 |
Cyr61 as a target for treatment and diagnosis of breast cancer
App 20040086504 - Sampath, Deepak ; et al. | 2004-05-06 |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
App 20040023910 - Zhang, Zhiming ; et al. | 2004-02-05 |
| 